While AP1 and MYC have long been associated with cancers, to our knowledge this is the first large scale test of the hypothesis that these TFs bind preferentially in cancer versus non-cancer models for cancer-related genes, and that they cooperate in binding. This evidence concerns the gene JUNB and cancer.